Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies

European Journal of Clinical Pharmacology

Volumn 62, Issue 8, 2006, Pages 661-665

  Heikkilä, Tiina ^a   Lekander, Tuula ^b   Raunio, Hannu ^c  

^a Lauttasaari Central Pharmacy   (Finland)

^b Kuusankoski I Community Pharmacy ^*  (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Community pharmacies; Computerised screening system; Drug interaction alerts; Prescriptions

Indexed keywords

ALDOSTERONE; ALPRAZOLAM; ALUMINUM; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CARBAMAZEPINE; CIPROFLOXACIN; DEXTROPROPOXYPHENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESOMEPRAZOLE; FLUCONAZOLE; FLUVOXAMINE; GEMFIBROZIL; IPRATROPIUM BROMIDE; IRON; ITRACONAZOLE; KETOCONAZOLE; LEVOFLOXACIN; MIDAZOLAM; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; POTASSIUM; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; UNINDEXED DRUG; WARFARIN;

ARTICLE; CLINICAL PHARMACY; CLOSED ANGLE GLAUCOMA; COMPUTER ANALYSIS; COMPUTER PROGRAM; DRUG ANTAGONISM; DRUG SURVEILLANCE PROGRAM; HUMAN; HYPERKALEMIA; INFORMATION PROCESSING; MEDICAL NEBULIZER; ONLINE SYSTEM; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; SEROTONIN SYNDROME;

COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; FINLAND; HUMANS; ONLINE SYSTEMS; PHARMACOEPIDEMIOLOGY; PROSPECTIVE STUDIES;

EID: 33746414814     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0149-4     Document Type: Article

References (20)

1. Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A (2005) Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med 165:189-192
2. Baxter K (Ed) Stockley's drug interactions. London: Pharmaceutical Press. Electronic version (2005)
3. Becker ML, Kallewaard M, Caspers PWJ, Schalekamp T, Stricker BHC (2005) Potential determinants of drug-drug interaction associated dispensing in community pharmacies. Drug Safety 28:371-378
4. Bjerrum L, Andersen M, Petersen G, Kragsturp J (2003) Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 21:153-158
5. Brosen K (2004) Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie 59:5-12
6. Buurma H, de Smet PAGM, van den Hoff OP, Egberts CG (2001) Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 52:85-91
7. Chen Y-F, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH (2005) Incidence and possible causes of prescribing potentially hazardous/ contraindicated drug combinations in general practice. Drug Saf 28:67-80
8. Egger SS, Drewe J, Schlienger RG (2003) Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 58:773-778
9. Glintborg B, Andersen SE, Dalhoff K (2005) Drug-drug interactions among recently hospitalised patients - frequent but mostly clinically insignificant. Eur J Clin Pharmacol 61:675-681
10. Halkin H, Katzir I, Kurman I, Jan J, Malkin BB (2001) Preventing drug interactions by online prescription screening in community pharmacies and medical practices. Clin Pharmacol Ther 69:260-265
11. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. JAMA 279:1200-1205
12. Merlo J, Liedholm H, Lindblad U, Björck-Linne A, Fält J, Lindberg G, Melander A (2001) Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 323:427-428
13. Roughead EE, Gilbert AL, Primrose JG, Sansom LN (1998) Drug-related hospital admission: a review of Australian studies published 1988-1996. Med J Aust 165:405-408
14. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:285-291
15. Sipilä J, Klaukka T, Martikainen J, Himberg J-J (1995) Occurrence of potentially harmful drug combinations among Finnish primary care patients. Int Pharm J 9:104-107
16. Tamblyn R, Huang A, Perreault R, Jacques A, Roy A, Hanley J, McLeod P, Laprise R (2003) The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 169:549-556
17. http://www.fass.se
18. http://www.multirec.com
19. http://www.receptum.fi
20. Yeom JH, Park JS, Oh OH, Shin HT, Oh JM (2005) Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea. Ann Pharmacother 39:1918-1923